Literature DB >> 8097101

Comparison of the effect of oral sulphasalazine, sulphapyridine and 5-amino-salicylic acid on the in vivo antibody response to oral and systemic antigen.

P Sheldon1, P Pell.   

Abstract

1. Mice, whose drinking water contained sulphasalazine, sulphapyridine or 5-amino-salicylic acid, received an antigenic challenge by cholera toxin administered either orally or systemically. 2. Sulphasalazine treated mice made less specific antibody of IgA class provided the antigen also was administered orally (P = 0.009 for days 7-28). When the antigen was administered systemically, there was a vigorous anti-cholera toxin antibody response of IgG class, and a lesser IgM but only a weak IgA response. The effect of sulphasalazine in this case was confined to the IgG response, which was significantly suppressed on day 28 (P = 0.008). 3. Sulphapyridine and 5-amino salicylic acid had no significant effect on the anti-cholera toxin (CT) responses of all three classes. 4. It therefore appears that in this model, only sulphasalazine is capable of influencing the humoral immune system, the antibody class affected depending on the route of entry of antigen. This may have implications for conditions such as rheumatoid arthritis and chronic inflammatory bowel disease, for which sulphasalazine has been found useful.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8097101      PMCID: PMC1381572          DOI: 10.1111/j.1365-2125.1993.tb05693.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  14 in total

1.  Effect of sulphasalazine on antibody response to oral antigen.

Authors:  P Sheldon; P Pell; A McBurney
Journal:  Br J Rheumatol       Date:  1992-12

2.  Inhibition of soybean lipoxygenase by sulfasalazine and 5-aminosalicylic acid: a possible mode of action in ulcerative colitis.

Authors:  J C Sircar; C F Schwender; M E Carethers
Journal:  Biochem Pharmacol       Date:  1983-01-01       Impact factor: 5.858

3.  Mode of action of sulphasalazine: an alternative view.

Authors:  A T Ali; G S Basran; J Morley
Journal:  Lancet       Date:  1982-02-27       Impact factor: 79.321

4.  Effect of magnesium on blood pressure.

Authors:  T Dyckner; P O Wester
Journal:  Br Med J (Clin Res Ed)       Date:  1983-06-11

5.  Gut mucosal, salivary and serum antitoxic and antibacterial antibody responses in Swedes after oral immunization with B subunit-whole cell cholera vaccine.

Authors:  M Jertborn; A M Svennerholm; J Holmgren
Journal:  Int Arch Allergy Appl Immunol       Date:  1984

6.  Role of Peyer's patch in the intestinal immune response to cholera toxin in enterically immunized rats.

Authors:  G A Enders; M Delius; S Ballhaus; W Brendel
Journal:  Infect Immun       Date:  1987-09       Impact factor: 3.441

7.  The long term effects of sulphasalazine in the treatment of rheumatoid arthritis and a comparative study with penicillamine.

Authors:  M Farr; E Tunn; A P Crockson; P A Bacon
Journal:  Clin Rheumatol       Date:  1984-12       Impact factor: 2.980

8.  Sulfasalazine treatment and lymphocyte function in patients with rheumatoid arthritis.

Authors:  D P Symmons; M Salmon; M Farr; P A Bacon
Journal:  J Rheumatol       Date:  1988-04       Impact factor: 4.666

9.  An experiment to determine the active therapeutic moiety of sulphasalazine.

Authors:  A K Azad Khan; J Piris; S C Truelove
Journal:  Lancet       Date:  1977-10-29       Impact factor: 79.321

10.  Inhibition of cytotoxicity by sulfasalazine. II. Sulfasalazine and sulfapyridine inhibit different stages of the NK and NKCF lytic processes.

Authors:  F Shanahan; A Niederlehner; R P MacDermott; W F Stenson; M G Kane; S Targan
Journal:  Immunopharmacology       Date:  1986-04
View more
  1 in total

1.  Evidence for differential effects of sulphasalazine on systemic and mucosal immunity in rheumatoid arthritis.

Authors:  L Kanerud; G N Engström; A Tarkowski
Journal:  Ann Rheum Dis       Date:  1995-04       Impact factor: 19.103

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.